Cargando…

Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study

BACKGROUND: Zimbabwe’s Ministry of Health and Child Care (MOHCC) adopted 2013 World Health Organization (WHO) prevention of mother-to-child HIV transmission (PMTCT) guidelines recommending initiation of HIV-positive pregnant and breastfeeding women (PPBW) on lifelong antiretroviral treatment (ART) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chadambuka, Addmore, Katirayi, Leila, Muchedzi, Auxilia, Tumbare, Esther, Musarandega, Reuben, Mahomva, Agnes I., Woelk, Godfrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526299/
https://www.ncbi.nlm.nih.gov/pubmed/28743251
http://dx.doi.org/10.1186/s12889-017-4611-2
_version_ 1783252786933137408
author Chadambuka, Addmore
Katirayi, Leila
Muchedzi, Auxilia
Tumbare, Esther
Musarandega, Reuben
Mahomva, Agnes I.
Woelk, Godfrey
author_facet Chadambuka, Addmore
Katirayi, Leila
Muchedzi, Auxilia
Tumbare, Esther
Musarandega, Reuben
Mahomva, Agnes I.
Woelk, Godfrey
author_sort Chadambuka, Addmore
collection PubMed
description BACKGROUND: Zimbabwe’s Ministry of Health and Child Care (MOHCC) adopted 2013 World Health Organization (WHO) prevention of mother-to-child HIV transmission (PMTCT) guidelines recommending initiation of HIV-positive pregnant and breastfeeding women (PPBW) on lifelong antiretroviral treatment (ART) irrespective of clinical stage (Option B+). Option B+ was officially launched in Zimbabwe in November 2013; however the acceptability of life-long ART and its potential uptake among women was not known. METHODS: A qualitative study was conducted at selected sites in Harare (urban) and Zvimba (rural) to explore Option B+ acceptability; barriers, and facilitators to ART adherence and service uptake. In-depth interviews (IDIs), focus group discussions (FGDs) and key informant interviews (KIIs) were conducted with PPBW, healthcare providers, and community members. All interviews were audio-recorded, transcribed, and translated; data were coded and analyzed in MaxQDA v10. RESULTS: Forty-three IDIs, 22 FGDs, and five KIIs were conducted. The majority of women accepted lifelong ART. There was however, a fear of commitment to taking lifelong medication because they were afraid of defaulting, especially after cessation of breastfeeding. There was confusion around dosage; and fear of side effects, not having enough food to take drugs, and the lack of opportunities to ask questions in counseling. Participants reported the need for strengthening community sensitization for Option B+. Facilitators included receiving a simplified pill regimen; ability to continue breastfeeding beyond 6 months like HIV-negative women; and partner, community and health worker support. Barriers included distance of health facility, non-disclosure of HIV status, poor male partner support and knowing someone who had negative experience on ART. CONCLUSIONS: This study found that Option B+ is generally accepted among PPBW as a means to strengthen their health and protect their babies. Consistent with previous literature, this study demonstrated the importance of male partner and community support in satisfactory adherence to ART and enhancing counseling techniques. Strengthening community sensitization and male knowledge is critical to encourage women to disclose their HIV status and ensure successful adherence to ART. Targeting and engaging partners of women will remain key determinants to women’s acceptance and adherence on ART under Option B+.
format Online
Article
Text
id pubmed-5526299
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55262992017-08-02 Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study Chadambuka, Addmore Katirayi, Leila Muchedzi, Auxilia Tumbare, Esther Musarandega, Reuben Mahomva, Agnes I. Woelk, Godfrey BMC Public Health Research Article BACKGROUND: Zimbabwe’s Ministry of Health and Child Care (MOHCC) adopted 2013 World Health Organization (WHO) prevention of mother-to-child HIV transmission (PMTCT) guidelines recommending initiation of HIV-positive pregnant and breastfeeding women (PPBW) on lifelong antiretroviral treatment (ART) irrespective of clinical stage (Option B+). Option B+ was officially launched in Zimbabwe in November 2013; however the acceptability of life-long ART and its potential uptake among women was not known. METHODS: A qualitative study was conducted at selected sites in Harare (urban) and Zvimba (rural) to explore Option B+ acceptability; barriers, and facilitators to ART adherence and service uptake. In-depth interviews (IDIs), focus group discussions (FGDs) and key informant interviews (KIIs) were conducted with PPBW, healthcare providers, and community members. All interviews were audio-recorded, transcribed, and translated; data were coded and analyzed in MaxQDA v10. RESULTS: Forty-three IDIs, 22 FGDs, and five KIIs were conducted. The majority of women accepted lifelong ART. There was however, a fear of commitment to taking lifelong medication because they were afraid of defaulting, especially after cessation of breastfeeding. There was confusion around dosage; and fear of side effects, not having enough food to take drugs, and the lack of opportunities to ask questions in counseling. Participants reported the need for strengthening community sensitization for Option B+. Facilitators included receiving a simplified pill regimen; ability to continue breastfeeding beyond 6 months like HIV-negative women; and partner, community and health worker support. Barriers included distance of health facility, non-disclosure of HIV status, poor male partner support and knowing someone who had negative experience on ART. CONCLUSIONS: This study found that Option B+ is generally accepted among PPBW as a means to strengthen their health and protect their babies. Consistent with previous literature, this study demonstrated the importance of male partner and community support in satisfactory adherence to ART and enhancing counseling techniques. Strengthening community sensitization and male knowledge is critical to encourage women to disclose their HIV status and ensure successful adherence to ART. Targeting and engaging partners of women will remain key determinants to women’s acceptance and adherence on ART under Option B+. BioMed Central 2017-07-25 /pmc/articles/PMC5526299/ /pubmed/28743251 http://dx.doi.org/10.1186/s12889-017-4611-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chadambuka, Addmore
Katirayi, Leila
Muchedzi, Auxilia
Tumbare, Esther
Musarandega, Reuben
Mahomva, Agnes I.
Woelk, Godfrey
Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study
title Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study
title_full Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study
title_fullStr Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study
title_full_unstemmed Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study
title_short Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study
title_sort acceptability of lifelong treatment among hiv-positive pregnant and breastfeeding women (option b+) in selected health facilities in zimbabwe: a qualitative study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526299/
https://www.ncbi.nlm.nih.gov/pubmed/28743251
http://dx.doi.org/10.1186/s12889-017-4611-2
work_keys_str_mv AT chadambukaaddmore acceptabilityoflifelongtreatmentamonghivpositivepregnantandbreastfeedingwomenoptionbinselectedhealthfacilitiesinzimbabweaqualitativestudy
AT katirayileila acceptabilityoflifelongtreatmentamonghivpositivepregnantandbreastfeedingwomenoptionbinselectedhealthfacilitiesinzimbabweaqualitativestudy
AT muchedziauxilia acceptabilityoflifelongtreatmentamonghivpositivepregnantandbreastfeedingwomenoptionbinselectedhealthfacilitiesinzimbabweaqualitativestudy
AT tumbareesther acceptabilityoflifelongtreatmentamonghivpositivepregnantandbreastfeedingwomenoptionbinselectedhealthfacilitiesinzimbabweaqualitativestudy
AT musarandegareuben acceptabilityoflifelongtreatmentamonghivpositivepregnantandbreastfeedingwomenoptionbinselectedhealthfacilitiesinzimbabweaqualitativestudy
AT mahomvaagnesi acceptabilityoflifelongtreatmentamonghivpositivepregnantandbreastfeedingwomenoptionbinselectedhealthfacilitiesinzimbabweaqualitativestudy
AT woelkgodfrey acceptabilityoflifelongtreatmentamonghivpositivepregnantandbreastfeedingwomenoptionbinselectedhealthfacilitiesinzimbabweaqualitativestudy